GJB2 and myocardial ischemia: This “proof-of-concept” study suggests that circulating EV-asso-ciated Cx26 may be an attractive biomarker of cardiomyocyte damage in cardiomyopa-thies characterized by oxidative stress and apoptosis, such as IHD and HF.